In the webinar, Dr. Matt Gurney, a European Veterinary Specialist, will review the use of gabapentin as an anxiolytic in cats. He will explore existing studies and provide detailed recommendations. Dr. Gurney, mainly interested in acute and chronic pain management, has extensive experience in anaesthesia and animal care.

The seminar discusses enhancing the management of Cushing’s syndrome in dogs from a general practice perspective. Topics include reliable diagnosis, evaluation of tests, understanding underlying causes, and key principles for successful management. Consideration is given to the disease’s possible effect on the animal and the owner’s quality of life. The presenter is Professor David Church, a seasoned small animal specialist and co-founder of VetCompass.

Trilostane effectively treats hyperadrenocorticism in dogs, but requires monitoring against potential adverse effects and risk of oversuppression of adrenocortical function. Monitoring methods, still under debate and research, include ACTH stimulation testing, pre-pill cortisol measurement, biochemical changes, and acute-phase protein measurement. An understanding of trilostane’s pharmacology and each monitoring method’s limitations is critical for optimal treatment outcomes.